Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Masafumi, Masuda"'
Autor:
Noriyuki Enomoto, Shogo Nakai, Shusuke Yazawa, Yasutaka Mochizuka, Atsuki Fukada, Yuko Tanaka, Hyogo Naoi, Yusuke Inoue, Hideki Yasui, Masato Karayama, Yuzo Suzuki, Hironao Hozumi, Kazuki Furuhashi, Mikio Toyoshima, Masato Kono, Shiro Imokawa, Masato Fujii, Taisuke Akamatsu, Naoki Koshimizu, Koshi Yokomura, Hiroyuki Matsuda, Yusuke Kaida, Yutaro Nakamura, Masahiro Shirai, Kazutaka Mori, Masafumi Masuda, Tomoyuki Fujisawa, Naoki Inui, Hiroaki Sugiura, Hiromitsu Sumikawa, Masashi Kitani, Kazuhiro Tabata, Noriyoshi Ogawa, Takafumi Suda
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-14 (2024)
Abstract Background Interstitial pneumonia with autoimmune features (IPAF), which does not meet any of the criteria for connective tissue diseases (CTD), has been attracting an attention in patients with idiopathic interstitial pneumonia (IIP). Howev
Externí odkaz:
https://doaj.org/article/d38798487a204e818e149454dbc5d89e
Autor:
Hideki Yasui, Naoki Inui, Tomoyuki Fujisawa, Masato Karayama, Noriyuki Enomoto, Yutaro Nakamura, Shigeki Kuroishi, Hisano Ohba, Koshi Yokomura, Jun Sato, Masaki Sato, Naoki Koshimizu, Mikio Toyoshima, Takashi Yamada, Masafumi Masuda, Toshihiro Shirai, Takafumi Suda
Publikováno v:
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 12 (2018)
Inhaled corticosteroids are widely used in the treatment of chronic obstructive pulmonary disease (COPD). However, their use has been questioned for appropriate dose and a possible increased risk of pneumonia. Here, we reviewed patients with COPD who
Externí odkaz:
https://doaj.org/article/42f07d03af3244768cadc4ec89999e5f
Autor:
Yoshikazu Inoue, Yasuhiko Yamano, Noriyoshi Ogawa, Shiro Imokawa, Yasuhiro Kondoh, Motoyasu Kato, Yoshio Taguchi, Masafumi Masuda, Noriyuki Enomoto, Hirofumi Chiba, Takafumi Suda, Kazutaka Mori, Hajime Takizawa, Yoshinori Tanino, Yasuhiko Nishioka, Mikio Toyoshima, Naoki Koshimizu, Yutaro Nakamura, Yusuke Kaida, Sakae Homma, Miho Kanai, Takehisa Sano, Hiroshi Mukae, Shinyu Izumi, Hiroyuki Matsuda, Naoki Hamada, Hironao Hozumi, Taisuke Akamatsu, Tomoyuki Fujisawa, Shigeo Muro, Takeshi Saraya, Koshi Yokomura, Naohiko Inase, Hiroshi Ishii, Shinobu Akagawa, Hironori Uruga
Publikováno v:
Thorax. 77:143-153
BackgroundSome patients with idiopathic interstitial pneumonia (IIP) show autoimmune features. Interstitial pneumonia with autoimmune features (IPAF) was recently proposed as a research concept in these patients. However, retrospective studies report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba1ee46207209101521be6304ad017d
https://doi.org/10.1136/thoraxjnl-2020-216263
https://doi.org/10.1136/thoraxjnl-2020-216263
Autor:
Kazuko Ikegaya, Junichi Tokuhama, Seiji Harada, Masafumi Masuda, Atsuko Saito, Kana Fushimi, Ken Tsuchiya, Hiroki Ashizawa, Kazuma Saratani
Publikováno v:
Japanese Journal of Infection Prevention and Control. 36:149-156
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af8bbbd5fb3f0ba29aea95d9050e89ad
https://doi.org/10.4058/jsei.36.149
https://doi.org/10.4058/jsei.36.149
Autor:
Taisuke Akamatsu, Toshihiro Shirai, Masato Kato, Dai Hashimoto, Hideki Yasui, Naoki Inui, Takafumi Suda, Koshi Yokomura, Hiroshi Hayakawa, Kyotaro Ide, Mikio Toyoshima, Shigeki Kuroishi, Kazumasa Yasuda, Hideki Suganuma, Takashi Yamada, Masafumi Masuda, Kingo Chida
Publikováno v:
Allergology International, Vol 61, Iss 2, Pp 323-329 (2012)
Background: Combination therapy with an inhaled corticosteroid (ICS) and a long-acting β2-agonist (LABA) in a single inhaler is the mainstay of asthma management and salmeterol/fluticasone combination (SFC) and fixed-dose formoterol/budesonide combi
Externí odkaz:
https://doaj.org/article/f41d6434bdca4ba6b63dd064c80b71d4
Autor:
Noriyuki Enomoto, Mikio Toyoshima, Naoki Koshimizu, Hiroyuki Matsuda, Takafumi Suda, Shiro Imokawa, Kazuhiro Asada, Tomoyuki Fujisawa, Yusuke Kaida, Yuzo Suzuki, Naoki Inui, Masafumi Masuda, Kazuki Furuhashi, Koushi Yokomura, Hiroshi Hayakawa, Hironao Hozumi, Takashi Yamada, Yutaro Nakamura, Hideki Kusagaya, Masato Karayama
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 14:1867-1877
Background Nivolumab, a programmed death 1 (PD-1) immune checkpoint inhibitor, has been shown to improve survival in non-small cell lung cancer (NSCLC). The possible involvement of PD-1 axis in the pathogenesis of inflammatory lung disease, such as c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ece68f795a490c02a12759c7253800a2
https://doi.org/10.2147/copd.s214610
https://doi.org/10.2147/copd.s214610
Autor:
Kouji Takamori, Junichi Tokuhama, Hiroshi Shibata, Seiji Harada, Atsuko Saito, Kazuma Saratani, Ken Tsuchiya, Yuri Kasezawa, Masafumi Masuda, Kazuko Ikegaya, Kana Fushimi
Publikováno v:
Japanese Journal of Infection Prevention and Control. 33:136-142
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ec1f67c6ece8c5dc3d61a8a3de789ea
https://doi.org/10.4058/jsei.33.136
https://doi.org/10.4058/jsei.33.136
Autor:
Kouji Takamori, Masafumi Masuda, Junichi Tokuhama, Kazuko Ikegaya, Hiroshi Shibata, Ken Tsuchiya, Kazuma Saratani, Kana Fushimi, Seiji Harada, Yuri Kasezawa, Atsuko Saito
Publikováno v:
Japanese Journal of Infection Prevention and Control. 33:56-61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbc6ed1922e99444100219596f34d088
https://doi.org/10.4058/jsei.33.56
https://doi.org/10.4058/jsei.33.56
Autor:
Yoshio Taguchi, M. Toyoshima, Hiroshi Ishii, Sakae Homma, Hiroki Takahashi, T. Suda, T. Akamatsu, S. Akagawa, H. Matsuda, Y. Yamano, Hiroshi Mukae, S. Imokawa, K. Yokomura, Yoshinori Tanino, Hajime Takizawa, Y. Inoue, Shigeo Muro, Y. Kaida, N. Koshimizu, H. Uruga, M. Kanai, Noriyuki Enomoto, Naohiko Inase, T. Sano, Motoyasu Kato, Masafumi Masuda, Yasuhiko Nishioka, S. Izumi, Naoki Hamada
Publikováno v:
B46. IDIOPATHIC INTERSTITIAL PNEUMONIA: NATURAL HISTORY.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91ca88276bab99883ba4f9e6fb8b08f9
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3390
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3390
Autor:
Kingo Chida, Shiro Imokawa, Mikio Toyoshima, Shigeki Kuroishi, Koshi Yokomura, Noriyuki Enomoto, Takashi Yamada, Masafumi Masuda, Toshihiro Shirai, Dai Hashimoto, Takafumi Suda, Hiroshi Hayakawa, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Kazutaka Mori
Publikováno v:
Respiratory Medicine. 119:1-6
Background The stepping down of asthma treatment can be considered when asthma symptoms have been well controlled with inhaled corticosteroids (ICSs)/long-acting β2 adrenergic agonists (LABAs). However, few data are available comparing the efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdac69219dd1c1d3b11646b6664bb932
https://doi.org/10.1016/j.rmed.2016.08.007
https://doi.org/10.1016/j.rmed.2016.08.007